Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2017

View Archived Issues

AMO Pharma and Ranedis collaborate on development of RND-001 for rare genetic diseases

Biocept and Catalyst agree to use liquid biopsy testing to screen for SCLC in Firdapse trial

Vedantra and Neon Therapeutuics collaborate on cancer vaccine research

MRC Technology licenses antibody to Newsummit for development in HCV

GABA(A) receptor inhibition stimulates retinal regeneration in novel zebrafish model

Mayo Clinic secures grant to study TapImmune's HER2-targeted vaccine for ductal carcinoma in situ

Allergan and Editas Medicine establish ocular research and development alliance

REGiMMUNE presents phase IIa data for RGI-2001

Lung Therapeutics initiates phase Ia/Ib study of LTI-01 to treat loculated pleural effusions

Targeting tumor-associated macrophage progenitors as a new strategy to impair tumor growth

FDA approves Keytruda for classical Hodgkin's lymphoma

Replicel completes phase I study of autologous cell therapy RCH-01 for androgenetic alopecia

Galectin Therapeutics reports promising results for GR-MD-02 in severe refractory atopic dermatitis

Pulmonary surfactant-associated protein D, a potential target for seasonal allergic rhinitis

Metriopharm reports topline results from phase IIa study of MP-1032 in plaque psoriasis

EnzymeBioSystems offers update on methyl amooranin

University of California, Oakland presents nitroxide spin-labeled compounds targeting beta-amyloid

New trial explores intracerebroventricular delivery of valproate for refractory epilepsy

Takeda Pharmaceutical patents histone deacetylase inhibitors

High PMS2 expression linked to reduced urothelial bladder cancer survival

Oncoceutics announces new DRD2 research collaborations with NIH

GeoVax Labs collaborates with American Gene Technologies on functional cure for HIV

CD300a found to play a role in atopic dermatitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...